chitosan has been researched along with mitoxantrone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jameela, SR; Jayakrishnan, A | 1 |
| Jameela, SR; Jayakrishnan, A; Latha, PG; Subramoniam, A | 1 |
| Lu, B; Xiong, SB; Yang, H; Yin, XD; Zhao, RB | 2 |
| Chen, H; Gao, F; Jiang, Q; Liu, L; Wang, Y; Yang, W; Yang, X; Zhang, Q | 1 |
| Cui, Z; Ping, Q; Qi, J; Song, Y; Zhuang, J | 1 |
| Chang, YC; Huang, KS; Kung, CP; Shaw, JF; Wang, CY; Yang, CH | 1 |
| Asghar, S; Chen, Z; Gao, S; Huang, L; Ping, Q; Xiao, Y; Xu, Y; Yin, L | 1 |
| Asghar, S; Chen, Z; Gao, S; Huang, L; Ping, Q; Wang, J; Xiao, Y; Yang, L; Zong, L | 1 |
| Asghar, S; Chen, Z; Huang, L; Jin, X; Ping, Q; Wang, J; Xiao, Y; Zong, L | 1 |
| Dousti, F; Hassanzadeh, F; Kasesaz, Y; Mirian, M; Rostami, M; Soleimanbeigi, M; Varshosaz, J | 1 |
| Alvi, SB; Bantal, V; Jogdand, AB; Nazia, B; Rajalakshmi, PS; Rengan, AK | 1 |
12 other study(ies) available for chitosan and mitoxantrone
| Article | Year |
|---|---|
Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Chelating Agents; Chitin; Chitosan; Cross-Linking Reagents; Drug Carriers; Glutaral; Kinetics; Microscopy, Electron, Scanning; Microspheres; Mitoxantrone; Muscle, Skeletal; Rats | 1995 |
Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Carcinoma, Ehrlich Tumor; Chitin; Chitosan; Drug Carriers; Male; Mice; Microspheres; Mitoxantrone | 1996 |
Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. II: Tissue distribution and pharmacodynamics.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Female; Humans; Injections; Lymph Nodes; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitoxantrone; Nanostructures; Neoplasm Transplantation; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine; Tissue Distribution; Toxicity Tests, Acute | 2006 |
Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. I: Formulation and in vitro characterization.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemistry, Pharmaceutical; Chitosan; Drug Stability; Freeze Drying; Hydrogen-Ion Concentration; In Vitro Techniques; Injections; Lymphatic Metastasis; Mitoxantrone; Nanotubes; Serum Albumin, Bovine; Solubility; Sterilization; Time Factors | 2006 |
Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan.
Topics: Chitosan; Drug Delivery Systems; Elements; Glycolates; Lactic Acid; Mitoxantrone; Nanospheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Surface Properties | 2009 |
Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes.
Topics: Animals; Antineoplastic Agents; Biophysical Phenomena; Chitosan; Coated Materials, Biocompatible; Drug Carriers; Drug Stability; Freeze Drying; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Injections, Intravenous; Liposomes; Materials Testing; Microscopy, Electron, Transmission; Mitoxantrone; Nanomedicine; Particle Size; Rats; Rats, Wistar | 2010 |
Microfluidic one-step synthesis of Fe₃O₄-chitosan composite particles and their applications.
Topics: Antineoplastic Agents; Chitosan; Drug Carriers; Ferrosoferric Oxide; Microfluidics; Mitoxantrone | 2014 |
Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mitoxantrone; Nanoparticles; Polyelectrolytes; Verapamil | 2017 |
Chitosan hydrochloride/hyaluronic acid nanoparticles coated by mPEG as long-circulating nanocarriers for systemic delivery of mitoxantrone.
Topics: Animals; Chitosan; Drug Carriers; Drug Liberation; Hyaluronic Acid; Male; Mitoxantrone; Nanoparticles; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley | 2018 |
Mitoxantrone-loaded chitosan/hyaluronate polyelectrolyte nanoparticles decorated with amphiphilic PEG derivates for long-circulating effect.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Chitosan; Drug Screening Assays, Antitumor; Electrolytes; Humans; Hyaluronic Acid; Male; MCF-7 Cells; Mice; Mitoxantrone; Nanoparticles; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Surface Properties; Surface-Active Agents | 2018 |
Boron phenyl alanine targeted ionic liquid decorated chitosan nanoparticles for mitoxantrone delivery to glioma cell line.
Topics: Antineoplastic Agents; Boron; Cell Line, Tumor; Chitosan; Glioma; Humans; Microscopy, Electron, Transmission; Mitoxantrone; Nanoparticle Drug Delivery System; Nanoparticles; Phenylalanine | 2021 |
Chitosan IR806 dye-based polyelectrolyte complex nanoparticles with mitoxantrone combination for effective chemo-photothermal therapy of metastatic triple-negative breast cancer.
Topics: Cell Line, Tumor; Chitosan; Doxorubicin; Humans; Hyperthermia, Induced; Mitoxantrone; Nanoparticles; Phototherapy; Photothermal Therapy; Polyelectrolytes; Triple Negative Breast Neoplasms | 2022 |